Press Kit
Salvat at a glance
If you are a media professional and wish to receive more information, please send us an email at media@svt.com.
Salvat’s News and Press kit
Media
Salvat at a glance
Press Kit
What are we doing right now
News
Media
Salvat’s News and Press kit
Media
Salvat at a glance
Press Kit
What are we doing right now
News
Media
Salvat at a glance
If you are a media professional and wish to receive more information, please send us an email at media@svt.com.
English Version PDF
What are we doing right now
These cookies collect information about how visitors make use of the website, such as page views, loading errors… It is generic and anonymous information where personal data are not included nor collects information that identifies visitors; with the ultimate aim to improve the functioning of the website.
| Cookie | Duration | Description |
|---|---|---|
| _ga | 2 years | Google Analytics |
| _gat_gtag_UA_112188601_1 | 2 years | Google Analytics |
| _gid | 2 years | Google Analytics |
These cookies are necessary for the proper use of the website, allowing access to sections that have security filters. Without these cookies, many of the features would not be operating.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| ip2location_redirection_first_visit | session | Mostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language |
| PHPSESSID | session | Identificador de sesión PHP / PHP session id |
| prescriptionModalAccepted | session | Identificador de sesión PHP / PHP session id |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| wpml_browser_redirect_test | session | Mostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language |
| _icl_visitor_lang_js | session | Mostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language |
Pediapharm Announces the Commercial Launch of Otixal™ in Canada
/in Salvat International /by adminsvtNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Pediapharm Inc. (“Pediapharm” or the “Company”) (TSX VENTURE:PDP) is pleased to announce today the Canadian commercial launch of Otixal™ (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution for the treatment of acute otitis media with tympanostomy tubes (“AOMT”) in […]
Salvat launches Ekzem
/in Salvat Spain /by adminsvtWe present Ekzem®, the first and only medicinal product indicated for the treatment of eczematous otitis externa Up until the recent release of Ekzem®, launched by SALVAT this January 2017, there was no medicinal product in Spain specifically indicated for the treatment of eczematous otitis externa. Up until now, otorhinolaryngologists, primary care physicians and other […]
Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC Announce the Launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution
/in Salvat USA /by adminsvtBARCELONA, Spain and ATLANTA, Aug. 29, 2016 /PRNewswire/ — Laboratorios SALVAT S.A. (SALVAT) and Arbor Pharmaceuticals, LLC (Arbor) jointly announce the launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution, the first and only antibiotic and steroid combination ear drop available in sterile, preservative-free single-dose vials. OTOVEL® is owned by SALVAT, […]